Cellectar Biosciences
CLRB
CLRB
44 hedge funds and large institutions have $24.2M invested in Cellectar Biosciences in 2021 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 11 increasing their positions, 6 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
34% less capital invested
Capital invested by funds: $36.9M → $24.2M (-$12.7M)
Holders
44
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.04M | |
| 2 | +$1M | |
| 3 | +$992K | |
| 4 |
Millennium Management
New York
|
+$368K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$252K |
Top Sellers
| 1 | -$1.93M | |
| 2 | -$1.88M | |
| 3 | -$1.77M | |
| 4 |
TLP
Tri Locum Partners
New York
|
-$1.37M |
| 5 |
MS
Maven Securities
St Helier,
Jersey
|
-$1.33M |